Buy & Sell TJX Companies Inc (TJX) – TJX Companies Inc Price Today
Aura AI Summary
Key Stats
- $163.03BMarket Cap
- Consumer CyclicalSector
- -10.89%3M Drawdown
- $170.29BEnterprise Value
- 1.3%Dividend Yield
- 44% Buy | 56% SellTrading Activity
- 94 daysTypical Hold Time
TJX Companies Inc (TJX) is currently valued at a market capitalization of $163.03B, with an enterprise value of $170.29B. Over the past 52 weeks, TJX Companies Inc has traded between a low of $121.35 and a high of $165, highlighting its annual price range. Over the past three months, TJX Companies Inc has recorded a drawdown of -10.89%, reflecting recent price volatility. TJX Companies Inc offers a dividend yield of 1.3%, with the most recent dividend of $0.48 paid on 14 May 26. On average, investors hold TJX Companies Inc for approximately 94 days, indicating typical investor behavior on the platform.
About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Most Recent News
Hedge funds boost semiconductor bets as SOXX ETF exposure hits record highs in Q1 2026
In the first quarter of 2026, hedge funds dramatically increased their investments in semiconductor stocks, pushing sector exposure to a record 19% of global hedge fund portfolios, more than doubling since the start of the year. Major investors like ...
Onconetix shares jump 23.65% after clinical study boosts confidence in prostate cancer test Proclarix.
Onconetix Inc. stock surged 23.65% in after-hours trading following positive clinical validation of its prostate cancer blood test, Proclarix. Two new peer-reviewed studies from Denmark showed Proclarix can reduce unnecessary biopsies and overdiagnos...
Concorso d’Eleganza Villa d’Este auction hits €40.8M sales with Ferrari Daytona SP3 leading at €6.25M
The 2026 Concorso d’Eleganza Villa d’Este auction by Broad Arrow Auctions achieved total sales of €40.8 million with an 87% sell-through rate. Ferrari models dominated, highlighted by a 2023 Daytona SP3 selling for €6.25 million. The event attracted ...